Symbiomics

Startup
Summarized by Halo AI

Symbiomics is a biotechnology firm that develops high-performance biological products for agriculture, using a proprietary platform with genomics, machine learning, and gene editing to create sustainable solutions for crop productivity.

Founded & HQ
Florianópolis, Santa Catarina, Brazil
Company size
11-50 employees
Funding
~$5.1M
IP status
3 grants confirmed
Activity highlights
Completed its Series A funding round led by Corteva Agriscience's investment platform, Corteva Catalyst, in June 2025.

Symbiomics is a Brazilian biotechnology company (founded in 2021) developing high-performance biological products for agriculture using microbiome, genomics/data science, and genome-editing/reprogramming approaches. Its portfolio targets multiple applications including crop nutrition, biocontrol, bioestimulants, and carbon sequestration, with development supported by partnerships and funding rounds to scale discovery, product testing, and go-to-market activities.[1][2][8]

AI summary generated on Jun 22, 2026
OpenAlexOpenAlex

For general inquiries

RC
Rodrigo Cano
Head of Business Development
Is this page yours? Boost its visibility
List technologies, facilities, services, or grant collaboration opportunities.

Key links

Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.